SEED Co., Ltd., founded in 1957, has established itself as a pioneer in the Health Care industry with a specific focus on contact lenses. Known for its corporate philosophy, "Supporting Your Vision with Japanese Quality," SEED has been an innovator since conducting Japan's first contact lens research using the molding method in 1951.
Over the decades, SEED has accumulated significant technological expertise and built substantial customer trust. The company’s product offerings are diverse, extending beyond traditional contact lenses to include solutions for farsightedness, astigmatism, bifocals, and colored lenses. SEED's strategic business expansion across more than 40 countries, primarily in Asia and Europe, underscores its commitment to catering to a global audience.
Despite its longstanding history, SEED shows no signs of decelerating, continuously evolving to meet the blurred boundaries of vision care. With its strong foundation and incessant innovation, SEED appears poised for sustained growth, making it a noteworthy consideration for venture capital or investors seeking stable investments in the healthcare sector.
